Intravenous anesthetics in sepsis

Acta Anaesthesiologica Taiwanica

Volumn 43, Issue 3, 2005, Pages 153-163

  Tsao, Cheng Ming ^e   Wu, Chin Chen ^a   Wang, Jhi Joung ^b,c   Wong, Chih Shung ^b   Tsai, Shen Kou ^e   Ho, Shung Tai ^b,d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anesthetic, intravenous; Sepsis; Shock, septic

Indexed keywords

4' CHLORODIAZEPAM; ALFENTANIL; ALPHA TOCOPHEROL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BUTYLCRESOL; CLONAZEPAM; DIAZEPAM; ENDOTOXIN; ETOMIDATE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; KETAMINE; LEUKOTRIENE B4; METHOHEXITAL; MIDAZOLAM; NITRIC OXIDE; PENTOBARBITAL; PLACEBO; PROPOFOL; THIOPENTAL; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADRENAL DISEASE; AMNESIA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; HEART DISEASE; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRAVENOUS ANESTHESIA; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POSTOPERATIVE PAIN; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SEPSIS; SEPTIC SHOCK; SIDE EFFECT;

ANESTHETICS, INTRAVENOUS; ANIMALS; CYTOKINES; FREE RADICALS; HUMANS; INFLAMMATION; NITRIC OXIDE; SEPSIS;

EID: 26944460336     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Gaylord HR, Simpson BT: Effect of certain anesthetics and loss of blood upon growth of transplanted mouse cancer. J Cancer Res 1:379, 1916.
2. Stevenson GW, Hall SC, Rudnick S, Seleny FL, Stevenson HC: The effect of anesthetic agents on the human immune response. Anesthesiology 72:542-552, 1990.
3. Imai T, Takahashi K, Masuo F, Goto F: Anaesthesia affects outcome of sepsis in mice. Can J Anaesth 45:360-366, 1998.
4. Muzio M, Naioli G, Saccani S, Levrero M, Mantovani A: The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097-2101, 1998.
5. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M: Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188:2091-2097, 1998.
6. Baldwin AS: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-681, 1996.
7. Morrison DC, Ulevitch RJ: The effects of bacterial endotoxins on host mediation systems. Am J Pathol 93:527-617, 1978.
8. Tracey KJ, Lowry SF, Cerami A: Cachectin/TNF-α in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 138:1377-1379, 1988.
9. Calandra T, Baumgartner JD, Gran GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP: Prognostic values of rumor necrosis factor/cachetin, interleukin-1, interferon alpha and interferon gamma in the serum of patients with septic shock. J Infect Dis 161:982-987, 1990.
10. Beutler BA, Cerami A: The biology of cachectin/TNF-α: A primary mediator of the host response. Ann Rev Immunol 7: 625-655, 1989.
11. Fischer E, Marano MA, Barber AE, Hudson A, Lee K, Rock CS, Hawes AS, Thompson RC, Hayes TJ, Anderson TD, et al: Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates. Am J Physiol 261: R442-452, 1991.
12. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, et al: Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370:218-220, 1994.
13. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D: Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1. J Exp Med 163:1363-1375, 1986.
14. Wanidworanun C, Strober W: Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 151:6853-6861, 1993.
15. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello, CA, Steere AC: Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341:146-148, 1993.
16. Crozier TA, Muller JE, Quittkat D, Sydow M, Wuttke W, Kettler D: Effect of anesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 72:280-285, 1994.
17. Gilliland HE, Armstrong MA, Carabine U, McMurray TJ: The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg 85:1394-1398, 1997.
18. Pirttikangas CO, Salo M, Mansikka M, Gronroos J, Pulkki K, Peltola O: The influence of anaesthetic technique upon the immune response to hysterectomy. A comparison of propofol infusion and isoflurane. Anaesthesia 50:1056-1061, 1995.
19. Roytblat L, Talmor D, Rachinsky M, Greemberg L, Pekar A, Appelbaum A, Gurman GM, Shapira Y, Duvdenani A: Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 87:266-271, 1998.
20. Pirttikangas CO: Dissertations from Scandinavia: Propofol emulsion anesthesia and the immune response. Acta Anaesthesia Scand 41:797-798, 1997.
21. Helmy SAK, Wahby MAM, El-Nawaway M: The effect of anesthesia and surgery on plasma cytokine production. Anaesthesia 54:733-738, 1999.
22. Rossano F, Tufano R, Cipollaro de L'Ero G, Servillo G, Baroni A, Tufano MA: Anesthetic agents induce human mononuclear leucocytes to release cytokines. Immunopharm Immunot 14: 439-450, 1992.
23. Salo M, Pirttikangas CO, Pulkki K: Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 52:341-344, 1997.
24. Galley HF, Dubbles A, Webster NR: The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 86:1289-1293, 1998.
25. Kawasaki T, Ogata M, Kawasaki C, Ogata JI, Inoue Y, Shigematsu A: Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 89:665-669, 1999.
26. Weigand MA, Schmidt H, Zhao Q, Plaschke K, Martin E, Bardenheuer HJ: Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 90:206-212, 2000.
27. DeForge LE, Remick DG: Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 174:18-24, 1991.
28. Takenaka I, Ogata M, Koga K. Matsumoto T, Shigematsu A: Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 80:402-408, 1994.
29. Idvall J, Ahlgren I, Aronsen KF, Stenberg P: Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 51: 1167-1173, 1979.
30. Schmidt H, Ebeling D, Bauer H, Bach A, Bohrer H, Gebhard MM, Martin E: Ketamine attenuates endotoxin-induced leukocyte adherence in rat mesenteric venules. Crit Care Med 23: 2008-2014, 1995.
31. Yu Y, Zhou Z, Xu J, Liu Z, Wang Y: Ketamine reduces NFκB activation and TNFα production in rat mononuclear cells induced by lipopolysaccharide in vitro. Ann Clin Lab Sci 32: 292-298, 2002.
32. Matsumoto T, Ogata M, Koga K, Shigematsu A: Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Ch 38:812-816, 1994.
33. Helmy SA, Al-Attiyah RJ: The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 56:4-8, 2001.
34. Ichiyama T, Nishikawa M, Lipton JM, Matsubara T, Takashi H, Furukawa S: Thiopental inhibits NF-κB activation in human glioma cells and experimental brain inflammation. Brain Res 911:56-61, 2001.
35. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
36. MacMicking J, Xie Q-W, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350, 1997.
37. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990.
38. Cobb JP, Danner RL: Nitric oxide and septic shock. JAMA 275:1192-1196, 1996.
39. Thiemermann C: The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28:45-79, 1994.
40. Wu CC, Croxtall JD, Perretti M, Bryant CE, Thiemermann C, Flower RJ, Vane JR: Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 92:3473-3477, 1995.
41. Oddis CV, Smmons RL, Hattler BG, Finkel MS: Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, Lnmma, on cardiac myocytes. Biochem Biophys Res Commun 205:992-997, 1994.
42. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD: The role of nitric oxide in cardiac depressioin induced by interleukin-1 beta and tumor necrosis factor-alpha. Br J Pharmacol 114:27-34, 1995.
43. Mikawa K, Nishina K, Tamada M, Takao Y, Maekawa N, Obara H: Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 26:905-911, 1998.
44. Park WK, Lynch C, Johns RA: Effects of propofol and thiopental in isolated rat aorta and pulmonary artery. Anesthesiology 77:956-963, 1992.
45. Petros AJ, Bogle RG, Pearson JD: Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells. Br J Pharmacol 109:6-7, 1993.
46. Gacar N, Gok S, Kalyoncu NI, Ozen I, Soykan N, Akturk G: The effect of endothelium on the response to propofol on bovine coronary artery rings. Acta Anaesthesiol Scand 39: 1080-1083, 1995.
47. Mikawa K, Nishina K, Kodama S, Obara H: Propofol attenuates diaphragmatic dysfunction induced by septic peritonitis in hamsters. Anesthesiology 94:652-660, 2001.
48. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T: Effects of propofol on hemodynamic and inflammatory response to endotoxemia in rats. Crit Care Med 28:1101-1106, 2000.
49. Taniguchi T, Kanakura H, Yamamoto K: Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 30:949-952, 2002.
50. Tsao CM, Ho ST, Chen A, Wang JJ, Tsai SK, Wu CC: Propofol ameliorates liver dysfunction and inhibits aortic superoxide level in conscious rats with endotoxic shock. Eur J Pharmacol 477:183-193, 2003.
51. Lin S-Z, Chiou A-L, Wang Y: Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats. Stroke 27:747-752, 1996.
52. Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T, Yoshiya I: Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br J Anaesth 77:238-242, 1996.
53. Li CY, Chou TC, Wong CS, Ho ST, Wu CC, Yen MH, Ding YA: Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages. Can J Anaesth 44:989-995, 1997.
54. Terasako K, Nakamura K, Yoda H, Kakuyama M, Hatano Y, Mori K: Barbiturates inhibit endothelium-dependent and independent relaxations mediated by cyclic GMP. Anesth Analg 78:823-830, 1994.
55. Terasako Nakamura K, Miyawaki I, Toda H, Kakuyama M, Mori K: Inhibitory effects of anesthetics on cyclic guanosine monophosphate (cGMP) accumulation in rat cerebellar slices. Anesth Analg 79:921-926, 1994.
56. Kim SO, Toda H, Nakamura K, Miyawaki I, Hirakata H, Hirata S, Mori K: Thiopental attenuates relaxation and cyclic GMP production in vascular smooth muscle of endotoxin-treated rat aorta, independent of nitric oxide production. Br J Anaesth 81:601-602, 1998.
57. Kesser P, Kronemann N, Hecker M, Busse R, Schini-Kerth VB: Effects of barbiturates on the expression of the inducible nitric oxide dynthase in vascular smooth muscle. J Cardiovas Pharmacol 30:802-810, 1997.
58. Pohlmann TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM: An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor ncerosis factor alpha increases neutrophils adherence by a CDw18-dependent mechanism. J Immunol 136:4548-4553, 1986.
59. Sugino K, Dohi K, Yamada K, Kawasaki T: Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants. Surgery 105:200-206, 1989.
60. Bautista AP, Spitzer JJ: Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol 259:G907-912, 1990.
61. Beckman J, Beckman T, Chen J, Marshall P. Freeman B: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990.
62. Jensen AG, Dahlgren C, Eintrei C: Propofol decreases random and chemotactic stimulated locomotion of human neutrophils in vitro. Br J Anaesth 70:99-100, 1993.
63. Kellermann W, Rothe G, Briegel J, Doenicke A, Peter K: Deterioration of respiratory burst of polymorphonuclear neutrophils by propofol. Anesthesiology 79:430, 1993.
64. Hofbauer R, Frass M, Salfinger H, Moser D, Hornykewycz S, Gmeiner B, Kapiotis S: Propofol reduces the migration of human leukocytes through endothelial cell monolayers. Crit Care Med 27:1843-1847, 1999.
65. Murphy PG, Ogilvy, Whiteley SM: The effect of propofol on the neutrophils respiratory burst. Eur J Anaesth 13:471-473, 1996.
66. Weiss M, Buhl R, Medve M, Schneider EM: Tumor necrosis factor-alpha modulates the selective interference of hypnotics and sedatives to suppress N-formyl-methionyl-leucyl-phenylalanine-induced oxidative burst formation in neutrophils. Crit Care Med 25:128-134, 1997.
67. O'Donnell NG, McSharry CP, Wilkinson PC, Asbury AJ: Comparison of the inhibitory effect of propofol, thiopentone and midazolam on neutrophils polarization in vitro in the presence or absence of human serum albumin. Br J Anaesth 69: 70-74, 1992.
68. Inada T, Taniuchi S, Shingu K, Kobayashi Y, Fujisawa J, Nakao SI: Propofol depressed neutrophils hydrogen peroxide production more than midazolam, whereas adhesion molecule expression was minimally affected by both anesthetics in rats with abdominal sepsis. Anesth Analg 92:437-441, 2001.
69. Musacchio E, Rizzoli V, Bianchi M, Bindoli A, Galzigna L: Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol 69:75-77, 1991.
70. Eriksson O, Pollesello P, Saris NL: Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anaesthetic propofol. Biochem Pharmacol 44:391-393, 1992.
71. Murphy PG, Bennett JR, Myers DS, Davies MJ, Jones JG: The effect of propofol anaesthesia on free radical-induced lipid peroxidation in rat liver microsomes. Eur J Anaesth 10: 261-266, 1993.
72. Green TR, Bennett SR, Nelson VM: Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 129:163-169, 1994.
73. Kahraman S, Demiryurek AT: Propofol is a peroxynitrite scanvenger. Anesth Analg 84:1127-1129, 1997.
74. Demiryurek AT, Cinel I, Kahraman S, Tecder-Unal M, Gogus N, Aypar U, Kanzik I: Propofol and intralipid interact with reactive oxygen species: A chemiluminescence study. Br J Anaesth 80:649-654, 1998.
75. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG: The antioxidant potential of propofol (2, 6-diisopropylphenol). Br J Anaesth 68:613-618, 1992.
76. Heine J, Leuwer M, Scheinichen D, Arseniev L, Jaeger K, Piepenbrock S: Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils. Br J Anaesth 77:387-392, 1996.
77. Bao YP, Williamson G, Tew D, Plumb GW, Lambert N, Jones JG, Menon DK: Antioxidant effects of propofol in human hepatic microsomes: Concentration effects and clinical relevance. Br J Anaesth 81:584-589, 1998.
78. Aarts L, van der Hee R, Dekker I, de Jong J, Langmeijer H, Bast A: The widely used anaethetic agent propofol can replace a-tocopherol as an antioxidant. FEBS Letters 357(Suppl 1):83-85, 1995.
79. Tsuchiya M, Asada A, Maeda K, Ueda Y, Sato EF, Shindo M, Inoue M: Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med 163:26-31, 2001.
80. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS: Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth 60:146-150, 1988.
81. Frohlich D, Rothe G, Schwall B, Schmitz G, Hobbhahn J, Taeger K: Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative responses to the bacterial peptide FMLP. Eur J Anaesth 13:582-8, 1996.
82. Weiss M, Mirow N, Birkhahn A, Schneider M, Wernet P: Benzodiazepines and their solvents influence neutrophil granulocyte function. Br J Anaesth 70:317-321, 1993.
83. Devlin EG, Clarke RS, Mirakhur RK, McNeill TA: Effect of four in induction agents on T-lymphocyte proliferations to PHA in viro. Br J Anaesth 73:315-317, 1994.
84. Ramamoorthy C, Kovarik WD, Winn RK, Harlan JM, Sharar SR: Neutrophil adhesion molecule expression is comparable in perinatal rabbits and humans. Anesthesiology 86:420-427, 1997.
85. Weigand MA, Schmidt H, Zhao Q, Plaschke K, Martin E, Bardenheuer HJ: Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 90:206-212, 2000.
86. Weiss M, Birkhahn A, Mettler S, Schneider M, Wernet P: Stereoselective suppression of neutrophils function by ketamine? Immunopharmacol Immunotoxicol 17:91-107, 1995.
87. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H, Niwa Y: The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophils functions. Anesth Analg 86:159-165, 1998.
88. Demopoulos HB, Flamm ES, Seligman ML, Jorgensen E, Ransohoff J: Antioxidant effects of barbiturates in model membranes undergoing free radical damage. Acta Neurol Scand 58:152-153, 1977.
89. Flamm ES, Demopulos H, Seligman M, Poser RG, Ranshoff J: Free radicals in cerebral ischemia. Stroke 9:445-447, 1978.
90. Smith DS, Rehncrona S, Westerberg E, Akesson B, Siesjo BK: Lipid peroxidation in brain tissue in vitro: Antioxidant effects of barbiturates. Acta Physiol Scand 105:527-529, 1979.
91. Weiss M, Buhl R, Birkhahn A, Mirow N, Schneidert M, Wernet P: Do barbiturates and their solutions suppress FMLP-induced neutrophil chemiluminescence? Eur J Anaesth 11: 371-379, 1994.
92. Frohlich D, Wittmann S, Rothe G, Schmitz G, Taeger K: Thiopental impairs neutrophil oxidative response by inhibition of intracellular signalling. Eur J Anaesthesiol 19:474-482, 2002.
93. Heller A, Heller S, Blecken S, Urbaschek R, Koch T: Effects of intravenous anesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand 42:518-526, 1998.
94. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992.
95. Marshall JC: Multiple organ dysfunction syndrome (MODS). In: Sibbald WJ, Vincent JL, eds. Clinical trails for the treatment of sepsis. Berlin: Springer, p122-138, 1995.
96. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 31:946-955, 2003.
97. Levy MM: The Surviving Sepisis Campaign. Adv Sepsis 3: 74, 2004.
98. Booke M, Armstrong C, Hinder F, Conroy B, Traber LD, Traber DL: The effects of propofol on hemodynamics and renal blood flow in healthy and in septic sheep, and combined with fentanyl in septic sheep. Anesth Analg 82:738-743, 1996.
99. Basu S, Mutschler DK, Larsson AO, Kiiski R, Nordgren A, Eriksson MB: Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 50:341-348, 2001.
100. Herr DL, Kelly K, Hall JB, Ulatowski J, Fulda GJ, Cason B, Hickey R, Nejman AM, Zaloga GP, Teres D: Safety and efficacy propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Med 26:S452-S462, 2000.
101. Hall RI, Sandham D, Cardinal P, Tweeddale M, Moher D, Wang X, Anis AH: Propofol vs midazolam for ICU sedation: A Canadian multicenter randomized trial. Chest 119:1151-1159, 2001.
102. Worek FS, Blumel G, Zeravik J, Zimmermann GJ, Pfeiffer UJ: Comparison of ketamine and pentobarbital anesthesia with the conscious state in a porcine model of Pseudomonas aeruginosa septicemia. Acta Anaesthesiol Scand 32:509-515, 1988.
103. Van der Linden P, Gilbart E, Engelman E, Schmartz D. De Rood M, Vincent JL: Comparison of halothane, isoflurane, alfentanil, and ketamine in experimental septic shock. Anesth Analg 70:608-617, 1990.
104. Koga K, Ogata M, Takenaka I, Matsumoto T, Shigematsu A: Ketamine suppresses tumor necrosis factor-a activity and mortality in carrageenan-sensitized endotoxin shock model. Circ Shock 44:160-168, 1994.
105. Galdiero F, Bentivoglio C, Nuzzo I, Ianniello R, Capasso C, Mattera S, Nazzaro C, Galdiero M, Romano Carratelli C: Effects of benzodiazepines on immunodeficiency and resistance in mice. Life Sci 57:2413-2423, 1995.